Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis

scientific article

Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1008763677
P356DOI10.1186/S13000-015-0380-3
P932PMC publication ID4537540
P698PubMed publication ID26276145
P5875ResearchGate publication ID281813580

P2093author name stringSheng-wen Wu
Cong-chao Ma
Wen-hui Li
P2860cites workUse of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.Q27824766
Extracting summary statistics to perform meta-analyses of the published literature for survival endpointsQ27860640
Measuring inconsistency in meta-analysesQ27860655
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogeneQ27860693
Practical methods for incorporating summary time-to-event data into meta-analysisQ28131754
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogeneQ28286890
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancerQ29547699
ERBB receptors and cancer: the complexity of targeted inhibitorsQ29619520
Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?Q30856729
Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomasQ33943812
HER-2 overexpression and survival in colorectal cancer: a meta-analysisQ33979049
Adjuvant trastuzumab in HER2-positive breast cancerQ35710898
Increasing incidence of colorectal cancer in Asia: implications for screeningQ36300753
c-erbB-2 is not a major factor in the development of colorectal cancerQ36644043
The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67Q37564008
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.Q40291966
Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinomaQ40981286
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cellsQ42807469
ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.Q47950050
Clinical role of HER-2/neu expression in colorectal cancer.Q51046708
Frequency of HER-2 positivity in rectal cancer and prognosis.Q51283402
Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases.Q51789617
Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.Q53091400
Clinico-Pathological and Prognostic Significance of p53, Bcl-2 and Her-2/neu Protein Markers in Colorectal Cancer Using Tissue Microarray.Q53317073
Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.Q53648066
Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.Q54280357
The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activityQ70141373
c-erbB-2 protein expression and clinicopathologic features in colorectal cancerQ73081149
The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancerQ73212054
The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancerQ74325369
Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survivalQ77432075
Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factorQ86876904
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
overexpressionQ61643320
P304page(s)144
P577publication date2015-08-16
P1433published inDiagnostic PathologyQ18397261
P1476titleDoes overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis
P478volume10

Reverse relations

cites work (P2860)
Q97525750Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
Q57183898Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
Q28078111HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
Q61816598Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib